Orexo AB Deals and Alliances Profile Introduction Orexo AB (Orexo) is engaged in the development of pharmaceutical products for the treatment of pain and inflammation. It has four marketed products namely; Abstral/Rapinyl, Edular, Diabact UBT and Heliprobe System. It has several pipeline products for the treatment of asthma, breakthrough cancer pain, insomnia, diagnosis of ulcer bacterium helicobacter pylori, rhinitis, incontinence, COPD, opioid addiction and chronic pain. It has entered into seveal worldwide partnership agreements with pharmaceutical companies to carry our sales and product development activities. The company is headquartered in Uppsala, Sweden. Global Market Directs Orexo AB Deals and Alliances Profile is the essential source for company data and information. The profile examines the companys key business structure and operations, history and products, as well as highlights the companys major recent financial deals. Scope Provides all the crucial company information required for business and competitor intelligence needs Gives information on the companys major recent financial deals. Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.Reasons to Purchase Obtain up to date company information. Support sales activities by understanding your customers businesses. Qualify prospective partners and suppliers. Understand and respond to your competitors business structure, strategy and prospects.
|
